R1 Therapeutics is debuting with an oversubscribed $77.5 million series A financing aimed at advancing its first-in-class ...

Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. M ore than one in sev ...

March 17 (Reuters) - R1 Therapeutics said on Tuesday it had launched operations with a $77.5 million Series A funding round and an exclusive license to develop and commercialize a drug for high ...

IgA nephropathy, an immune assault on the kidneys, is often missed. New treatments mean that spotting it sooner might save lives ...

Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership with Alebund Pharmaceuticals to gain exclusive global ...

A commentary by Calvin Meaney urges discontinuation of outdated tests that are imprecise or disadvantage Black patients.

Kidney failure, also known as end-stage renal disease (ESRD), occurs when kidneys lose their ability to filter waste and excess fluids from the blood effectively. This serious condition affects ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

When it comes to dealing with chronic illnesses, prevention is always better than cure. That was the point made by concerned ...

March is National Kidney Month. Learn how to protect your kidney health, recognize symptoms, and reduce your risk of disease.

A Japanese registry has identified a blind spot in the routine care of patients with chronic kidney disease (CKD). Serum bicarbonate levels are rarely measured, leaving metabolic acidosis largely ...